Ninety One North America’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.71M | Hold |
7,390
| – | – | 0.17% | 81 |
|
|
2026
Q1 | $3.63M | Buy |
7,390
+48
| +0.7% | +$26.1K | 0.16% | 75 |
|
|
2025
Q4 | $4.25M | Buy |
+7,342
| New | +$4.15M | 0.17% | 70 |
|
|
2025
Q2 | – | Sell |
-2,205
| Closed | -$1.1M | – | 69 |
|
|
2025
Q1 | $1.1M | Sell |
2,205
-352
| -14% | -$191K | 0.07% | 58 |
|
|
2024
Q4 | $1.33M | Sell |
2,557
-335
| -12% | -$184K | 0.08% | 57 |
|
|
2024
Q3 | $1.79M | Buy |
+2,892
| New | +$1.71M | 0.12% | 49 |
|
|
2023
Q3 | – | Sell |
-12,356
| Closed | -$6.45M | – | 87 |
|
|
2023
Q2 | $6.45M | Sell |
12,356
-492
| -4% | -$265K | 0.27% | 45 |
|
|
2023
Q1 | $7.41M | Sell |
12,848
-493
| -4% | -$278K | 0.34% | 34 |
|
|
2022
Q4 | $7.35M | Buy |
13,341
+94
| +0.7% | +$49.8K | 0.36% | 32 |
|
|
2022
Q3 | $6.72M | Hold |
13,247
| – | – | 0.32% | 33 |
|
|
2022
Q2 | $7.2M | Buy |
13,247
+6,122
| +86% | +$3.37M | 0.32% | 35 |
|
|
2022
Q1 | $4.21M | Buy |
7,125
+305
| +4% | +$175K | 0.15% | 77 |
|
|
2021
Q4 | $4.55M | Sell |
6,820
-271
| -4% | -$169K | 0.16% | 80 |
|
|
2021
Q3 | $4.05M | Buy |
7,091
+135
| +2% | +$74.1K | 0.19% | 74 |
|
|
2021
Q2 | $3.51M | Sell |
6,956
-127
| -2% | -$59.9K | 0.16% | 83 |
|
|
2021
Q1 | $3.23M | Sell |
7,083
-17,355
| -71% | -$8.28M | 0.19% | 84 |
|
|
2020
Q4 | $11.4M | Sell |
24,438
-756
| -3% | -$354K | 0.7% | 38 |
|
|
2020
Q3 | $11.1M | Buy |
25,194
+1,754
| +7% | +$725K | 1.22% | 25 |
|
|
2020
Q2 | $8.49M | Sell |
23,440
-36,764
| -61% | -$12.3M | 0.88% | 23 |
|
|
2020
Q1 | $17.1M | Sell |
60,204
-32,751
| -35% | -$10.3M | 1.42% | 30 |
|
|
2019
Q4 | $30.2M | Sell |
92,955
-10,412
| -10% | -$3.16M | 2.46% | 8 |
|
|
2019
Q3 | $30.1M | Buy |
103,367
+5,215
| +5% | +$1.49M | 2.72% | 5 |
|
|
2019
Q2 | $28.8M | Buy |
98,152
+9,961
| +11% | +$2.74M | 2.54% | 9 |
|
|
2019
Q1 | $24.1M | Sell |
88,191
-23,929
| -21% | -$5.96M | 2.28% | 11 |
|
|
2018
Q4 | $25.1M | Sell |
112,120
-1,090
| -1% | -$256K | 2.67% | 8 |
|
|
2018
Q3 | $27.6M | Sell |
113,210
-19,954
| -15% | -$4.59M | 2.37% | 8 |
|
|
2018
Q2 | $27.6M | Sell |
133,164
-705
| -0.5% | -$150K | 1.98% | 15 |
|
|
2018
Q1 | $27.6M | Buy |
133,869
+62,019
| +86% | +$13M | 2.1% | 13 |
|
|
2017
Q4 | $13.6M | Sell |
71,850
-3,175
| -4% | -$608K | 2.17% | 15 |
|
|
2017
Q3 | $14.2M | Buy |
75,025
+5,626
| +8% | +$1.02M | 2.4% | 8 |
|
|
2017
Q2 | $12.1M | Buy |
69,399
+58,227
| +521% | +$9.78M | 2.22% | 16 |
|
|
2017
Q1 | $1.72M | Sell |
11,172
-204
| -2% | -$31.2K | 0.32% | 50 |
|
|
2016
Q4 | $1.6M | Sell |
11,376
-131
| -1% | -$19.3K | 0.24% | 75 |
|
|
2016
Q3 | $1.83M | Hold |
11,507
| – | – | 0.25% | 81 |
|
|
2016
Q2 | $1.7M | Buy |
11,507
+1,600
| +16% | +$236K | 0.25% | 80 |
|
|
2016
Q1 | $1.4M | Buy |
9,907
+880
| +10% | +$118K | 0.23% | 80 |
|
|
2015
Q4 | $1.28M | Hold |
9,027
| – | – | 0.23% | 75 |
|
|
2015
Q3 | $1.1M | Buy |
9,027
+242
| +3% | +$31.5K | 0.28% | 69 |
|
|
2015
Q2 | $1.14M | Hold |
8,785
| – | – | 0.37% | 49 |
|
|
2015
Q1 | $1.18M | Hold |
8,785
| – | – | 0.37% | 48 |
|
|
2014
Q4 | $1.1M | Buy |
+8,785
| New | +$1.07M | 0.32% | 56 |
|
Other funds holding TMO
RG
ECSS
LT
Ninety One North America's TMO Position: Q2 2026 in Review
Ninety One North America held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 7,390 shares worth $3.71M. The position accounts for 0.17% of the portfolio, ranked #81.
Ninety One North America first reported a position in TMO in Q4 2014 and has held it in 41 quarters since. The position peaked at $30.2M in Q4 2019. 1,133 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Ninety One North America held 7,390 shares of Thermo Fisher Scientific worth $3.71M as of Q2 2026.
- Ninety One North America left its Thermo Fisher Scientific share count unchanged in Q2 2026.
- Thermo Fisher Scientific made up 0.17% of Ninety One North America's portfolio in Q2 2026, its #81 holding.
- Ninety One North America first reported a position in Thermo Fisher Scientific in Q4 2014 and has held it in 41 quarters since.
- Ninety One North America's Thermo Fisher Scientific position peaked at $30.2M in Q4 2019.
- 1,133 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Ninety One North America's 13F filing for Q2 2026, filed 16 Jul 2026.